皇家华人

header-logo
GettyImages-609179959-hero
headshot

Yee Chung Cheng, MD

Associate Professor

view physician profile

Locations

  • Zablocki VA Medical Center
  • Froedtert Hospital
  • Zablocki VA Medical Center
  • Breast Care Center - Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • Chinese (Mandarin), Taiwanese, Chinese (Cantonese), English

To Schedule an Appointment Call

Education

  • MD - Doctor of Medicine

Biography

Yee Chung Cheng, MD, joined the Medial College of Wisconsin in 2004. He is currently an Associate Professor of Medicine in the Division of Hematology and Oncology, and the associate program director of the Hematology and Oncology Fellowship program. Dr. Cheng practices at both Froedtert Hospital/Clinical Cancer Center where he specializes and focuses his research in breast cancer, and at Clement J. Zablocki VA Medical Center where he serves as the Section Chief of Hematology and Oncology.

Dr. Cheng has completed his general Hematology and Oncology training at Baylor College of Medicine, Houston, Texas and also a specialized Blood and Marrow Transplantation training at the University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Research Interests

His initial research interest was in the potential use of high-dose chemotherapy with hematopoietic stem cell transplantation in breast cancer. Currently his research interest is in the development of clinical trials focus on the investigative use of chemotherapy and/or novel therapy in high risk breast cancer included triple negative breast cancer or inflammatory breast cancer.

Together with his breast cancer colleagues at Froedtert Hospital/Clinical Cancer Center, Dr. Cheng has formed an inflammatory breast cancer (IBC) team to join the international IBC Connect organization led by the University of Texas M. D. Anderson Cancer Center, Houston, Texas. With the close collaboration with other renowned cancer centers in the world, we aim to provide the state of art management to inflammatory breast cancer in the state of Wisconsin.

Publications

  • (Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN.) WMJ. 2023 Dec;122(5):418-421 PMID: 38180937 SCOPUS ID: 2-s2.0-85181850540 01/05/2024

  • (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H.) Breast Cancer Res Treat. 2023 Oct;201(3):387-396 PMID: 37460683 PMCID: PMC10795510 SCOPUS ID: 2-s2.0-85164922339 07/18/2023

  • (Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H.) Res Sq. 2023 Apr 07 PMID: 37066270 PMCID: PMC10104267 04/18/2023

  • (Thapa B, Arobelidze S, Clark BA, Xuefei J, Daw H, Cheng YC, Patel M, Spiro TP, Haddad A.) Cureus. 2022 Aug;14(8):e28551 PMID: 36185859 PMCID: PMC9517584 10/04/2022

  • (Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC.) J Cancer. 2022;13(8):2472-2476 PMID: 35711833 PMCID: PMC9174868 SCOPUS ID: 2-s2.0-85130459904 06/18/2022

  • (Brown SA, Sparapani R, Osinski K, Zhang J, Blessing J, Cheng F, Hamid A, Berman G, Lee K, BagheriMohamadiPour M, Lal JC, Kothari AN, Caraballo P, Noseworthy P, Johnson RH, Hansen K, Sun LY, Crotty B, Cheng YC, Olson J, Cardio-Oncology Artificial Intelligence Informatics & Precision (CAIP) Research Team Investigators.) Am Heart J Plus. 2022 Jan;13 PMID: 35434676 PMCID: PMC9012235 04/19/2022

  • (Fujii T, Masuda H, Cheng YC, Yang F, Sahin AA, Naoi Y, Matsunaga Y, Raghavendra A, Sinha AK, Fernandez JRE, James A, Yamagishi K, Matsushima T, Schuetz R, Tripathy D, Tada S, Jackson RS, Noguchi S, Nakamura S, Acoba JD, Ueno NT.) Breast Cancer Res Treat. 2021 Sep;189(2):455-461 PMID: 34131830 06/17/2021

  • (Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C.) Endocrinology. 2021 Aug 01;162(8) PMID: 33735382 SCOPUS ID: 2-s2.0-85111784651 03/19/2021

  • (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR.) WMJ. 2018 Jun;117(2):62-67 PMID: 30048574 SCOPUS ID: 2-s2.0-85051516380 07/27/2018

  • (Dong L, Yuan Y, Opansky C, Chen Y, Aguilera-Barrantes I, Wu S, Yuan R, Cao Q, Cheng YC, Sahoo D, Silverstein RL, Ren B.) Oncotarget. 2017 Apr 04;8(14):22550-22562 PMID: 28186980 PMCID: PMC5410244 SCOPUS ID: 2-s2.0-85016933174 02/12/2017

  • (Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N.) J Cancer. 2017;8(6):1009-1017 PMID: 28529613 PMCID: PMC5436253 05/23/2017

  • (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC.) J Cancer. 2012;3:145-51 PMID: 22481980 PMCID: PMC3319980 04/07/2012

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.